Clinical Trial Update: Medium-term Effects of Treatments in Autoimmune Encephalitis

View source ↗

Summary

Recruitment is ongoing for a study led by Hospices Civils de Lyon to assess medium-term effects of treatments across multiple autoimmune encephalitis subtypes, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Caspr2 Antibody-associated Encephalitis
• Gad65 Autoimmune Encephalitis
• Gfap Astrocytopathy
• Iglon5 Antibody-associated Encephalitis
• Lgi1 Antibody-associated Encephalitis
• Nmdar Autoimmune Encephalitis

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: NMDAR Autoimmune Encephalitis, LGI1 Antibody Associated Encephalitis | Status: RECRUITING